Life Science Tools Market Worth $227.3 Billion by 2028 | CAGR: 11.9%

Life Science Tools Industry Overview

The global life science tools market size is expected to reach USD 227.3 billion by 2028, expanding at a CAGR of 11.9% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in different life science tools are expected to enhance their adoption among prominent end users of the market, thereby leading to the market growth. For instance, improvements in quantitative accuracy, MS resolution, and information sciences have enhanced the accuracy and utility of mass spectrometry-based methods in the field of proteomics.

Products such as Cell Culture Systems and 3D Cell Culture, Flow Cytometry, PCR and qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, and Transfection Devices and Gene Delivery Technologies have witnessed substantial growth after the COVID-19 pandemic. Novel research has suggested the use of a flow cytometry-based method for COVID-19 testing. Researchers have also used the technique to explore types of T cells involved in COVID-19 immune responses.

Life Science Tools Market Segmentation

Grand View Research has segmented the global life science tools market on the basis of technology, product, end-use, and region:

Based on the Technology Insights, the market is segmented into Genomic Technology, Proteomics Technology, Cell Biology Technology, Other Analytical & Sample Preparation Technology, and Lab Supplies & Technologies

• The cell biology technology segment dominated the market for life science tools and accounted for the largest revenue share of 33.9%in 2020.
• In recent times, the genomics industry has witnessed a substantial number of advancements and expansion of the application of gene editing tools for the treatment of genetic diseases.
• The proteomics segment is expected to expand at a significant CAGR as proteome analysis can provide a complete depiction of functional and structural information of the cell and their response mechanisms against drugs and other foreign factors.

Based on the Product Insights, the market is segmented into Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning & Genome Engineering, Microscopy & Electron Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Devices & Gene Delivery Technologies, NMR, Other Separation Technologies, and Other Products & Services

• The cell culture systems and 3D cell culture segment dominated the market for life science tools and accounted for the largest revenue share of 17.9% in 2020.
• The PCR and qPCR segment witnessed substantial growth from 2019 to 2020 owing to high utilization in COVID-19 diagnosis.
• The nucleic acid microarray segment is expected to expand at the fastest CAGR.

Based on the End-use Insights, the market is segmented into Government & Academic, Biopharmaceutical Company, Health Care, Industry, and Others

• The health care segment dominated the market for life science tools and accounted for the largest revenue share of 33.7% in 2020.
• Increasing adoption of genomic and proteomic workflows in hospitals to diagnose and treat several clinical abnormalities is expected to drive the market for life science tools.

Life Science Tools Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Mergers and acquisition, divestments, and new product development and launch are the key strategies adopted by the established market players while some emerging players are involved in obtaining funding for their product development and launch.

Some prominent players in the global Life Science Tools market include:

• Agilent Technologies
• Becton, Dickinson and Company
• Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Illumina, Inc.
• Thermo Fisher Scientific, Inc
• QIAGEN

Order a free sample PDF of the Life Science Tools Market Intelligence Study, published by Grand View Research.

Intragastric Balloons Market End-user, Business Drivers, and Competitive Analysis by 2028

Intragastric Balloons Industry Overview

The global intragastric balloons market size is expected to reach USD 100.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.9% from 2021 to 2028. The rise in obesity and increasing demand for minimally invasive procedures are anticipated to be key market drivers.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options leading to a rise in demand for effective minimally invasive weight-loss treatment options.

Intragastric Balloons Market Segmentation

Grand View Research has segmented the intragastric balloons market on the basis of administration, balloon type, filling material, end use, and region:

Based on the Administration Insights, the market is segmented into Pill Form and Endoscopy

• The endoscopy segment dominated the market for the intragastric balloon and held the largest revenue share of 69.8% in 2020.
• The pill form segment is anticipated to witness lucrative growth over the forecast period.

Based on the Type Insights, the market is segmented into Single, Dual, and Triple

• The single segment dominated the market for the intragastric balloon and held the largest revenue share of 75.2% in 2020
• The triple segment is anticipated to witness lucrative growth over the forecast period.

Based on the Filling Material Insights, the market is segmented into Saline Filled and Gas Filled

• The saline-filled segment dominated the market for the intragastric balloon and held the largest revenue share of 71.1% in 2020 due to the high product availability and significant weight loss produced by these systems.
• The gas-filled intragastric balloons segment is anticipated to grow at a rapid pace over the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, and Ambulatory Surgical Centers

• The hospital segment dominated the market for the intragastric balloon and held the largest revenue share of 44.8% in 2020.
• The ambulatory surgical centers are anticipated to witness rapid growth over the forecast period due to high costs of hospitalization, rise in demand for minimally invasive procedures and treatment options.

Intragastric Balloons Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Mergers and acquisition, divestments, and new product development and launch are the key strategies adopted by the established market players while some emerging players are involved in obtaining funding for their product development and launch.

Some prominent players in the global Intragastric Balloons market include:

• Apollo Endosurgery, Inc.
• Obalon Therapeutics, Inc.
• Allurion Technologies, Inc.
• Spatz3
• Helioscopie
• Endalis
• MEDSIL
• ReShape Medical, Inc.
• Lexel Medical

Order a free sample PDF of the Intragastric Balloons Market Intelligence Study, published by Grand View Research.

Key Players Operating in The Neurovascular Catheters Market Include Biomerics, Acandis GmbH, and Spiegelberg GmbH & Co. KG

Neurovascular Catheters Industry Overview

The global neurovascular catheters market size is anticipated to reach USD 4.83 billion by 2028, expanding at a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.

Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country.

Neurovascular Catheters Market Segmentation

Grand View Research has segmented the global neurovascular catheters market on the basis of type, application, end-use, and region:

Based on the Type Insights, the market is segmented into Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters, and Others

• In 2020, the embolization catheters segment dominated the market with a revenue share of over 25.0%.
• The microcatheters segment is expected to expand at the highest revenue-based CAGR of 7.6% during the forecast period.

Based on the Application Insights, the market is segmented into Embolic Stroke, Brain Aneurysm, Arteriovenous Malformations, and Others

• In 2020, the brain aneurysm segment dominated the market with a revenue share of more than 30.0% owing to factors such as the increasing incidence of brain aneurysms, new product launches by various market players, and increasing awareness among the population about the treatment of brain aneurysm.
• The others segment is expected to register the highest revenue-based CAGR of 7.2% during the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Diagnostic Centers

• The hospitals segment dominated the market in 2020 and held a revenue share of more than 50.0%.
• The ambulatory surgical centers segment is expected to expand at the highest revenue-based CAGR of 7.8% during the forecast period.

Neurovascular Catheters Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key market players are focusing on the launch of innovative types of medical devices, growth strategies, and technological advancements.

Some prominent players in the global Neurovascular Catheters market include:

• Medtronic
• Stryker
• phenox GmbH
• Penumbra, Inc.
• Integer Holdings Corporation
• Terumo Corporation
• Integra LifeSciences Corporation
• Biomerics
• Acandis GmbH
• Spiegelberg GmbH & Co. KG.

Order a free sample PDF of the Neurovascular Catheters Market Intelligence Study, published by Grand View Research.

Advanced Therapy Medicinal Products Market to grow at a CAGR of 13.2% by 2028

Advanced Therapy Medicinal Products Industry Overview

The global advanced therapy medicinal products market size is expected to reach USD 21.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. The ATMPs (Advanced Therapy Medicinal Products) exhibit the potential to cure diseases by addressing their root cause rather than symptomatic treatment. Thus, ATMPs help deliver transformative advantages which are not offered by conventional treatments. These factors are expected to drive the market over the forecast period.

The breakthrough approvals of Tecartus and Abecma post-approval of Zolgensma, Kymriah, and Yescarta have bolstered the exceptional advancements in this space. These approvals have spurred the investment flow in this arena thereby driving revenue growth. Key companies are adopting various operation models to accelerate the product manufacturing process.

The COVID-19 pandemic has triggered the application of advanced therapies in virology research to a major extent. A study was issued in December 2020 which stated the potential of T-cell therapy for the treatment of high-risk COVID-19 infected individuals. Prior to this, in September 2020, the U.S. FDA has approved the ALVR109 (an allogeneic T-cell therapy IND application) designed for the treatment of COVID-19 patients.

Advanced Therapy Medicinal Products Market Segmentation

Grand View Research has segmented the global advanced therapy medicinal products market on the basis of therapy type and region:

Based on the Therapy Type Insights, the market is segmented into Cell Therapy, Gene Therapy, CAR-T Therapy, and Tissue Engineered Product

• The tissue-engineered product segment dominated the market with the largest revenue share of 39.0% in 2020.
• The cell therapy segment accounted for the largest revenue share in 2020 owing to the presence of a high number of approved products in this segment
• On the other hand, the CAR-T therapy segment is gaining significant momentum in the space and is expected to register the fastest CAGR over the forecast period.

Advanced Therapy Medicinal Products Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The growing investments by key market players to develop advanced systems for healthcare management are contributing to the market growth. Leading healthcare providers and hospitals have renewed or entered licensing deals with the IT solutions providers to use their products available in the market, which is anticipated to enhance the market growth.

Some prominent players in the global Advanced Therapy Medicinal Products market include:

• Allscripts Healthcare Solutions, Inc.
• Cerner Corporation
• NXGN Management, LLC
• McKesson Corporation
• Koninklijke Philips N.V.
• Hill-Rom Services Inc.
• Cisco
• General Electric
• Stanly Healthcare
• Vocera Communications
• ASCOM
• athenahealth, Inc.

Order a free sample PDF of the Advanced Therapy Medicinal Products Market Intelligence Study, published by Grand View Research.

Clinical Workflow Solutions Market Analysis Report by Product, Application and Demand, 2028

Clinical Workflow Solutions Industry Overview

The global clinical workflow solutions market size is expected to reach USD 19.25 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 12.4% from 2021 to 2028. An increased volume of patient health information due to the rising prevalence of chronic conditions and the high demand for better quality care by patients is expected to fuel the adoption of workflow software and services in healthcare settings. Rising awareness amongst the caregivers and patients pertinent to the benefits of integrated solutions and interest in reliable technology for efficient decision-making is anticipated to fuel the adoption of workflow solutions.

The interoperability and compatibility of the systems with different platforms due to their robust technology have enhanced the growth prospects for the market. Collaborative efforts by software developers along with researchers to make healthcare information available to users are projected to contribute to the lucrative growth over the forecast period. Furthermore, strategic initiatives intended by the industry participants for developing end-to-end solutions are expected to boost the competition in the market.

The unprecedented COVID-19 pandemic positioned substantial pressure on health care providers worldwide. Not only did health systems manage the real and expected entry of infectious patients through emergent response, but they were also obligatory to address variable factors comprising ensuring appropriate critical care capacity, enabling supply chain needs for personal protective equipment, the high demand for medical devices, and addressing ongoing staffing challenges. In this regard, connected care technologies have been established and they have proved very supportive as they permit healthcare providers to monitor patients using connected devices. Hospitals are more and more focusing on building their competencies by integrating various hospital structures with EHRs.

Clinical Workflow Solutions Market Segmentation

Grand View Research has segmented the global clinical workflow solutions market on the basis of type, end use, and region:

Based on the Type Insights, the market is segmented into Data Integration Solutions, Real-time Communication Solutions, Workflow Automation Solutions, Care Collaboration Solutions, and Enterprise Reporting & Analytics Solutions

• The data integration solutions segment dominated the market with a revenue share of over 26.0% in 2020.
• The care collaboration solutions segment is expected to witness lucrative growth over the forecast period owing to the increased emphasis on patient-centric services.

Based on the End-use Insights, the market is segmented into Hospitals, Ambulatory Care Centers, and Long-term Care Facilities

• The hospitals segment dominated the market with a revenue share of over 45.0% in 2020 owing to the applicability, rising number of healthcare facilities, and associated data that needs proper management along with privacy.
• Ambulatory care centers are anticipated to witness lucrative growth over the forecast period owing to the hike in outpatient admissions.
• With the rising demand for home healthcare, providers are introducing newer technologies and software to improve the quality of services being provided.

Clinical Workflow Solutions Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The growing investments by key market players to develop advanced systems for healthcare management are contributing to the market growth. Leading healthcare providers and hospitals have renewed or entered licensing deals with the IT solutions providers to use their products available in the market, which is anticipated to enhance the market growth.

Some prominent players in the global Clinical Workflow Solutions market include:

• Allscripts Healthcare Solutions, Inc.
• Cerner Corporation
• NXGN Management, LLC
• McKesson Corporation
• Koninklijke Philips N.V.
• Hill-Rom Services Inc.
• Cisco
• General Electric
• Stanly Healthcare
• Vocera Communications
• ASCOM
• athenahealth, Inc.

Order a free sample PDF of the Clinical Workflow Solutions Market Intelligence Study, published by Grand View Research.

The Demand for Wound Irrigation Systems Market is on the Rise Owing To Increasing Prevalence of Chronic Diseases

Wound Irrigation Systems Industry Overview

The global wound irrigation system market size is expected to reach USD 380.03 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.8% from 2021 to 2028. The rising prevalence of chronic wounds, increasing number of surgical procedures, technological advancements, favorable initiatives taken by the private and public sectors, and the increasing cases of burns across the globe are the key factors driving the market.

A wound irrigation system allows rapid healing of deep wounds and surgical site infections. It also allows improved wound cleansing that prevents further complications. The increasing prevalence of chronic wounds and the rising number of surgical procedures are the key factors driving the market. For instance, as per a report published by ScienceDirect in 2018, the surgical infection has the highest prevalence rate of around 4.0%, followed by diabetic foot ulcers of around 3.4%. In addition, the rising number of wound care centers across the globe is expected to surge the demand for wound irrigation systems.

Wound Irrigation Systems Market Segmentation

Grand View Research has segmented the global wound irrigation system market on the basis of the product, application, and region:

Based on the Product Insights, the market is segmented into Manual and Battery-operated

• The manual wound irrigation system segment accounted for the largest revenue share of 55.45% in 2020.
• The battery-operated wound irrigation system is anticipated to witness the fastest growth over the forecast period.

Based on the Application Insights, the market is segmented into Chronic Wounds, Burns, Surgical Wounds, and Traumatic Wounds

• The chronic wounds segment accounted for the largest revenue share of 33.59% in 2020.
• The chronic wounds segment is anticipated to witness the fastest growth over the forecast period. The increasing cases of chronic diseases, especially diabetes, across the globe are fueling the segment growth.

Wound Irrigation Systems Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are adopting various strategies such as mergers & acquisitions, product launches, and partnerships to strengthen their foothold in the market.

Some prominent players in the global Wound Irrigation Systems market include:

• Zimmer Biomet
• Stryker Corporation
• Centurion Medical Products
• BSN Medical
• Cooper Surgical Inc.
• R. Bard, Inc.
• Bionix
• Westmed, Inc.

Order a free sample PDF of the Wound Irrigation Systems Market Intelligence Study, published by Grand View Research.

Medical Affairs Outsourcing Market is expected to grow at a Compound Annual Growth Rate of 12.2% by 2028

Medical Affairs Outsourcing Industry Overview

The global medical affairs outsourcing market size is expected to reach USD 3.47 billion by 2028 registering a CAGR of 12.2%, according to a new report by Grand View Research, Inc. Transformation in medical education and the rising number of orphan therapies for the treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market. According to a report published by IQVIA in 2020, the U.S. FDA has approved 80 orphan indications in 2017 and about 57 in early 2020.

The market is growing at a significant rate due to the surge in clinical trials. Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, the pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.

Medical Affairs Outsourcing Market Segmentation

Grand View Research has segmented the global medical affairs outsourcing market on the basis of services, industry, and region:

Based on the Services Insights, the market is segmented into Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information, and Others

• Medical writing & publishing was the largest service segment in 2020 and accounted for a revenue share of 35%.
• The medical science liaisons (MSLs) segment is anticipated to register the fastest CAGR of 12.8% from 2021 to 2028.

Based on the Industry Insights, the market is segmented into Pharmaceutical, Biopharmaceutical, and Medical Devices

• The pharmaceutical segment held the largest market share of over 52% in 2020 and is estimated to retain its leading position throughout the forecast years.
• The pharmaceutical industry has been experiencing slow growth, delayed drug approvals, and insufficiency in the pharma production supply chain has anticipated a long-term impact on the pharmaceutical sector due to the global pandemic.
• The biopharmaceutical segment is anticipated to register the fastest CAGR of over 13.5%. The biopharma industry is focusing more on the core activities related to drug development, which is expected to drive demand for medical affairs outsourcing services in the segment.

Medical Affairs Outsourcing Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Most of the companies are focusing on various growth strategies, such as partnerships, merger & acquisitions, and product portfolio expansion to retain their market position.

Some prominent players in the global Medical Affairs Outsourcing market include:

• ICON plc
• IQVIA Holdings, Inc.
• The Medical Affairs Company
• Syneos Health, Inc.
• Pharmaceutical Product Development, LLC
• Ashfield Healthcare Communications
• Zeincro Group
• Wuxi Clinical Development, Inc.
• SGS S.A.
• Indegene, Inc.

Order a free sample PDF of the Medical Affairs Outsourcing Market Intelligence Study, published by Grand View Research.

Increasing Awareness Initiatives Is Expected To Boost the Pelvic Floor Electric Stimulator Market Growth

Pelvic Floor Electric Stimulator Industry Overview

The global pelvic floor electric stimulator market size is anticipated to reach USD 427.15 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.5% from 2021 to 2028. Increasing prevalence of urinary incontinence, rising investment in research and development by key players, and growing awareness initiatives are some of the major factors anticipated to boost the market growth.

The increasing prevalence of chronic diseases and Urinary Incontinence (UI) are primary factors that are expected to drive the market growth. According to the NHS, around 61% of the male population is suffering from lower Urinary Tract Infections (UTI) and around 34% of women are living with some type of UI. This disorder costs around USD 301.40 million per year to the NHS, thereby, contributing to the market growth.

Factors such as the rising prevalence of neurodegenerative disorders, growing geriatric population, rising demand for home healthcare, and increasing use of medical sensors in various treatments are further expected to boost the market growth. The rapid rise in the geriatric population at higher risk of urinary incontinence is also one of the key factors responsible for the increasing demand for pelvic floor electric stimulators.

Pelvic Floor Electric Stimulator Market Segmentation

Grand View Research has segmented the global pelvic floor electric stimulator market based on application and region:

Based on the Application Insights, the market is segmented into Urinary Incontinence, Neurodegenerative Diseases, and Sexual Dysfunction

• The UI segment led the market with a share of 84.87% in 2020 owing to the increasing prevalence of stress and urge incontinence, and product launches by key players.
• However, the sexual dysfunction segment is expected to expand at the highest CAGR of 12.0% from 2021 to 2028.
• Products introduced by the top players in the market, increasing awareness about the treatment of sexual dysfunction through pelvic floor electric stimulator, and rising prevalence of sexual dysfunction are a few factors that may drive market growth in the future.

Pelvic Floor Electric Stimulator Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Several market players engage in mergers and acquisitions to strengthen their market position. This strategy enables companies to increase their capabilities, expand their product portfolios, and improve competencies.

Some prominent players in the global Pelvic Floor Electric Stimulator market include:

• Zynex Inc.
• TensCare Ltd.
• Verity Medical Ltd.
• InControl Medical
• The Prometheus Group
• Laborie, Inc.
• ActivLife Technologies
• Athena Feminine Technologies
• Atlantic Therapeutics
• Renovia Inc.

Order a free sample PDF of the Pelvic Floor Electric Stimulator Market Intelligence Study, published by Grand View Research.

Key Factor Driving the Growth to Insulin Pump Market is Increasing Awareness about Diabetes Preventive Care

Insulin Pump Industry Overview

The global insulin pump market size is expected to reach USD 8.3 billion, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.7% from 2021 to 2028. The key factors driving the growth of the market are the technological advancements and the adoption of pumps over traditional methods. These pumps are very convenient for people who require daily multiple injections of insulin.

Insulin pump is a machine that enables insulin to be delivered either manually or automatically. These pumps can be programmed to deliver a specific set of doses and can also deliver a larger set of doses of glucose whenever required, such as before a meal. Patients can connect these devices to their smartphones to calibrate blood glucose readings. Technological advancement and new product launches across the globe are also fueling the market during the forecast period. For instance, Medtronic’s MiniMed 670G system is the world’s first hybrid closed loop system that acts as an artificial pancreas. The system provides automated insulin delivery as per the patient’s CGM readings.

Insulin Pump Market Segmentation

Grand View Research has segmented the global insulin pump market on the basis of type, product, accessories, end-use, and region:

Based on the Type Insights, the market is segmented into Patch Pumps and Tethered Pumps

• The tethered pumps segment dominated the market and accounted for the largest revenue share of 78.5% in 2020. The segment is expected to witness a CAGR of 9.5% during the forecast period.
• The patch pump segment is expected to witness a robust CAGR of around 10.0% during the forecast period.

Based on the Product Insights, the market is segmented into MiniMed (630G, 670G, and VEO), Accu-Chek (Combo, Insight, and Solo), Tandem (T: slim X2, G4, T: flex Delivery System), Omnipod, My Life Omnipod, and Others

• Medtronic’s MiniMed insulin pumps segment dominated the market and captured the largest revenue share of around 50.0% in 2020 owing to the high adoption rate and advancement in technology.
• The tandem pump segment is expected to exhibit the highest CAGR of 11.2% during the forecast period.

Based on the Accessories Insights, the market is segmented into Insulin reservoir or cartridges, Insulin set insertion devices, and Battery

• The insulin set insertion devices segment dominated the market and accounted for the largest revenue share of 41.3% in 2020.
• The insulin reservoir or cartridges segment is expected to witness a substantial growth rate of CAGR of 9.01% during the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals & Clinics, Homecare, and Laboratories

• The hospitals and clinics segment dominated the market and accounted for the largest revenue share of 44.8% in 2020 and is expected to maintain its dominance over the forecast period.
• The homecare segment is expected to witness the fastest CAGR of 9.17% during the forecast period.

Insulin Pump Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and the launch of new technologically advanced products and services to strengthen their foothold in the market. Key players are significantly investing in research and development to manufacture technologically advanced products.

Some prominent players in the global Insulin Pump market include:

• Medtronic plc
• Hoffmann-La Roche Ltd.
• Tandem Diabetic Care, Inc.
• Insulet Corporation
• Ypsomed
• Cellenovo
• Sooil Development
• Valeritas, Inc.
• JingasuDelfu Co., Ltd.

Order a free sample PDF of the Insulin Pump Market Intelligence Study, published by Grand View Research.

Breast Cancer Diagnostics Market Growth Can Be Credited To the Increasing Prevalence of Cancer, 2028

Breast Cancer Diagnostics Industry Overview

The global breast cancer diagnostics market size is expected to reach USD 6.8 billion by 2028, according to a new study by Grand View Research Inc. The market is expected to expand at a CAGR of 7.0% from 2021 to 2028. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Breast Cancer Diagnostics Market Segmentation

Grand View Research has segmented the global breast cancer diagnostics market on the basis of type, product, application, end-use, and region:

Based on the Type Insights, the market is segmented into Imaging, Biopsy, Genomic Tests, Blood Tests, and Others

• The imaging segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of 73.6% in 2020.
• The blood tests segment is projected to be the fastest-growing segment during the forecast period due to several research studies being carried out globally by the research organizations and major players.

Based on the Product Insights, the market is segmented into Platform-based Products and Instrument-based Products

• The instrument-based testing segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of 72.7% in 2020.
• The platform-based products segment is anticipated to witness the fastest growth over the forecast period, owing to the novelty of products and the higher preference of such products for the targeted therapy.

Based on the Application Insights, the market is segmented into Screening, Diagnostic and Predictive, Prognostic, and Research

• The diagnostics and predictive application segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of around 47.6% in 2020.
• The prognostic segment is expected to witness a significant CAGR over the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals & Clinics, Diagnostic Centers and Medical Laboratories, and Others

• The hospitals and clinics segment dominated the market for breast cancer diagnostics and accounted for the largest revenue share of around 50.2% in 2020.
• The diagnostic centers and medical laboratories segment is expected to witness a significant growth rate over the forecast period due to an increase in the number of initiatives undertaken by governments to provide various services, such as reimbursement for diagnostic tests.

Breast Cancer Diagnostics Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The key companies are adopting strategies such as mergers and acquisitions and partnerships, to acquire a larger market share, globally.

Some prominent players in the global Breast Cancer Diagnostics market include:

• Hologic Inc.
• Genomic Health (Exact Sciences Corporation)
• BD
• Danaher
• Koninklijke Philips N.V.
• QIAGEN
• Thermo Fisher Scientific Inc.
• Myriad Genetics
• Argon Medical Devices, Inc.
• Hoffmann-La Roche Ltd.

Order a free sample PDF of the Breast Cancer Diagnostics Market Intelligence Study, published by Grand View Research.

Key Factor Boosting the Per Diem Nurse Staffing Market Growth include Increasing Number of Healthcare Facilities

Per Diem Nurse Staffing Industry Overview

The global per diem nurse staffing market size is expected to reach USD 11.1 billion by 2028, registering a CAGR of 4.9% over the forecast period, according to a new report by Grand View Research, Inc. Higher demand for medical-surgical nurses & increased utilization of staffing agencies, and the rising demand for family nurse practitioners are driving the market. The rising geriatric population leads to an increase in the number of hospital admissions, which is another key factor boosting the market growth.

Moreover, the spread of infectious diseases, especially during flu season, is an important factor resulting in a sudden increase in the number of hospital admissions, thereby creating the need for additional nursing staff. For example, according to the Centers for Disease Control and Prevention (CDC), an estimated 959,000 people were hospitalized because of the 2017-2018 influenza season in the U.S. Similarly, the 2018-2019 flu season accounted for 69,000-84,000 hospital admissions in the U.S.

Such temporary need for an additional nurse workforce can be easily fulfilled by per diem nurses, thereby augmenting the market growth. The COVID-19 pandemic has increased the pressure on the medical workforce. With hospitals being overburdened with COVID-19 patients, the demand for per diem nurse staffing is increasing exponentially. At this point, the main aim of healthcare facilities is to deploy the maximum number of medical staff for the management of COVID-19 patients.

Thus, the pandemic is driving market growth. With more patients being hospitalized, more nurses are required for the care, which is impelling the need for temporary nurses. According to June Pulse Survey by Staffing Industry Analysts (SIA), the demand for pre diem staffing increased by 6% during the COVID-19 pandemic. However, lower job security and stringent regulations are creating negativity in nurses to work as per diem nurses, which is a big challenge to the market.

Per Diem Nurse Staffing Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The market is fragmented with the presence of well-established as well as small-scale players, leading to higher competition among smaller players to sustain their market position. The high demand for nursing services by healthcare facilities leads to the adoption of various strategies, such as mergers & acquisitions, by players to maintain their market stronghold.

Some prominent players in the global Per Diem Nurse Staffing market include:

• Cross Country Healthcare, Inc.
• Health trust Workforce Solutions
• Maxim Healthcare Group
• Supplemental Healthcare
• Accountable Healthcare Staffing
• AMN Healthcare
• Nurse Staffing LLC
• GHR Healthcare
• Interim HealthCare, Inc.
• CareerStaff Unlimited

Order a free sample PDF of the Per Diem Nurse Staffing Market Intelligence Study, published by Grand View Research.

Surgical Snares Market is primarily driven by Increase in the Preference Keyhole Surgeries

Surgical Snares Industry Overview

The global surgical snares market size is expected to reach USD 2.1 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.4% from 2021 to 2028. The market is primarily driven by various factors such as an increase in the number of endoscopic ambulatory surgery centers and polypectomy procedures and the growing preference for minimally invasive surgeries. A significant increase in the number of gastrointestinal procedures in the U.S. and other developed economies is anticipated to support the market growth over the forecast period. Moreover, the increasing prevalence of chronic kidney diseases, the growing geriatric population suffering from chronic conditions, and increasing patient awareness are among the factors aiding in the market growth. Favorable reimbursement policies in major markets are promoting demand for surgical snares in various medical procedures.

A constant rise in the geriatric population is leading to an increase in the financial burden on the healthcare system. According to the Population Reference Bureau, the number of people in the U.S. aged 65 and above is estimated to nearly double from 52 million in 2018 to 95 million by 2060. Such a rise in the elderly population is expected to subsequently result in greater demand for ablation devices for the treatment of tumors, thereby boosting the market growth.

Surgical Snares Market Segmentation

Grand View Research has segmented the global surgical snares market on the basis of usability, application, end use, and region:

Based on the Usability Insights, the market is segmented into Single-use and Reusable

• The single-use segment accounted for the largest revenue share of over 60.0% in 2020.
• The reusable segment is expected to witness the fastest growth over the forecast period. Cost-effectiveness offered by disposable devices is expected to be a growth factor.

Based on the Application Insights, the market is segmented into GI Endoscope, Laparoscopy, Urology Endoscopy, Gynecology Endoscopy, Arthroscopy, Bronchoscopy, Mediastinoscopy, Laryngoscopy, and Others

• GI endoscope held the largest share of over 30.0% in 2020.
• Arthroscopy is expected to expand at the fastest rate over the forecast period. The adoption of arthroscopic procedures is expected to increase owing to the rising geriatric population at risk of age-related disorders, such as arthritis, and rising incidence of joint injuries such as that of knee and shoulder.
• Laparoscopy held a significant share in 2020.

Based on the End-use Insights, the market is segmented into Hospitals and Ambulatory Surgical Centers

• The hospitals segment captured the largest share of over 75.0% in 2020.
• Ambulatory surgical centers (ASCs) are anticipated to register the highest growth rate over the forecast period.

Surgical Snares Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The competition is highly dynamic with new entrants entering the market with the innovative product portfolio and major players maintaining their market share with mergers and acquisitions.

Some prominent players in the global Surgical Snares market include:

• Medtronic
• Boston Scientific Corporation
• Medline Industries, Inc.
• Olympus Corporation
• Cook
• CONMED Corporation
• Steris (U.S.)
• Merit Medical Systems
• Avalign Technologies
• Hill-Rom Holdings, Inc.
• Sklar Surgical Instruments

Order a free sample PDF of the Surgical Snares Market Intelligence Study, published by Grand View Research.

T-cell Therapy Market is expected to Expand at a Compound Annual Growth Rate of 20.2% by 2028

T-cell Therapy Industry Overview

The global T-cell therapy market size is expected to reach USD 20.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 20.2% from 2021 to 2028. The milestone approvals of Kymriah and Yescarta along with the recent approval of Tecartus have bolstered the exponential revenue growth in the market.

The commercial launch of these innovative therapies across various regions has spurred the investment flow in this arena thereby driving the market. Cancer indications are the major investment targets for the key operating players. However, space is constantly expanding to include other indications such as viral infections, creating lucrative opportunities for the operating players.

T-cell Therapy Market Segmentation

Grand View Research has segmented the T-cell therapy market on the basis of modality, therapy type, indications, and regions:

Based on the Modality Insights, the market is segmented into Research and Commercialized

• The research segment dominated the market for T-cell therapy and accounted for more than 75.0% of revenue share in 2020 owing to the high number of products in the clinical development phase.
• The commercial base is expected to witness growth owing to the increasing regulatory approvals for commercial products across various countries as well as a rise in the number of medical centers implementing these therapies

Based on the Type Insights, the market is segmented into CAR T-cell Therapy, T Cell Receptor (TCR)-based, and Tumor-Infiltrating Lymphocytes (TIL)-based

• In 2020, CAR T-cell therapy segment dominated the market for T-cell therapy and accounted for the largest revenue share of 82.0% in 2020. This is owing to the exponential rise in the number of clinical trials for CAR-T therapies and the increasing involvement of key players in this arena.
• esides this, T-cell receptor-based therapies pegged the second position in the global space owing to their potential in the treatment of solid tumors. This segment is gaining significant attention for the treatment of melanoma.

Based on the Indication Insights, the market is segmented into Hematologic Malignancies, Solid Tumors, and Others

• In 2020, the hematologic malignancies segment dominated the market for T-cell therapy and accounted for a 49.0% revenue share.
• Given the high number of market entities entering the market and high fixed costs of autologous cell manufacturing, the segment is expected to witness high market competition in the near future.

T-cell Therapy Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key companies are undertaking various strategic initiatives to maintain their market position

Some prominent players in the global T-cell Therapy market include:

• Novartis AG
• Merck KGaA
• Gilead Sciences Inc.
• TCR2 Therapeutics Inc
• Bluebird Bio Inc.
• Sorrento Therapeutics
• Fate Therapeutics
• Pfizer Inc.
• Amgen
• Celgene Corporation

Order a free sample PDF of the T-cell Therapy Market Intelligence Study, published by Grand View Research.

Traditional Wound Management Market Revenue is driven by Rising Number of Ambulatory Surgical Centers

Traditional Wound Management Industry Overview

The global traditional wound management market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.7% from 2021 to 2028. The global increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the key driving factors for market growth. Factors such as the adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are majorly contributing to the rise in the prevalence of non-communicable diseases.

Cancer has been a global healthcare burden as it is one of the leading causes of death. Most surgical wounds post-cancer surgery are relatively large in size and deep, producing exudate that requires regular care. The rising incidence of chronic diseases, increasing number of accidents, and rising number of ambulatory surgery centers (ASCs) are the key driving factors for the market.

Traditional Wound Management Market Segmentation

Grand View Research has segmented the global traditional wound management market on the basis of product, application, end-use, and region:

Based on the Product Insights, the market is segmented into Gauze, Tape, Bandage, and Cotton

• The gauze segment dominated the market for traditional wound management and accounted for the largest revenue share of around 49.0% in 2020.
• The tapes segment is anticipated to witness the fastest growth rate over the forecast period.

Based on the Application Insights, the market is segmented into Chronic Wounds and Acute Wounds

• The acute wounds segment dominated the market and accounted for the largest revenue share of 59.9% in 2020.
• Chronic wounds are anticipated to witness the fastest growth over the forecast period. The increasing cases of chronic diseases, especially diabetes, and the rising geriatric population across the globe are the major driving factors for the segment growth.

Based on the End-use Insights, the market is segmented into Hospitals, Clinics, Home Healthcare, and Others

• The hospitals' segment dominated the market and held the largest revenue share of 45.4% in 2020.
• The home healthcare segment is anticipated to witness the fastest growth over the forecast period.

Traditional Wound Management Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers and acquisitions, product launches, and partnerships to strengthen their position in the market.

Some prominent players in the global Traditional Wound Management market include:

• Braun Melsungen AG
• Johnson & Johnson Pvt. Ltd.
• Medtronic PLC
• Smith & Nephew
• PAUL HARTMANN AG
• Cardinal Health
• Mölnlycke Health Care AB
• Derma Sciences Inc.
• Medline Industries, Inc.
• BSN Medical

Order a free sample PDF of the Traditional Wound Management Market Intelligence Study, published by Grand View Research.

Key Players of Ophthalmic Ultrasound Devices Market include Optos, Escalon Medical Corp, and Appasamy associates

Ophthalmic Ultrasound Devices Industry Overview

The global ophthalmic ultrasound devices market size is expected to reach USD 787.7 million by 2028, registering a CAGR of 8.36% over the forecast years, according to a new report by Grand View Research, Inc. Increasing incidence of diabetes, rising prevalence of ophthalmic disorders, such as cataract and proliferative diabetic retinopathy, growing awareness about cataract surgeries, and the introduction of technologically advanced ophthalmic ultrasounds are among the major factors anticipated to drive the market during the forecast period.

The rising burden of ophthalmic ailments, such as retinal & cataract detachments, and increased demand for effective and efficient imaging tools are further expected to drive the market growth. In addition, numerous novel product launches and technological advancements are expected to contribute to the market growth during the forecast period.

Ophthalmic Ultrasound Devices Market Segmentation

Grand View Research has segmented the global ophthalmic ultrasound devices market on the basis of product, mobility, end-use, and region:

Based on the Product Insights, the market is segmented into A-Scan, B-Scan, Combined, Pachymeter, and Ultrasound Bio Microscope

• The A-scan product segment held the largest market share of 29.6% in 2020.
• The B-scan segment is expected to grow at a CAGR of 8.30% during the forecast period. The increasing reach of these compact, affordable, lightweight, and multifunctional devices is expected to fuel the segment growth.

Based on the Mobility Insights, the market is segmented into Standalone and Portable

• The standalone devices segment held the largest revenue share of more than 54% in 2020 owing to the factors, such as affordability and easy availability & handling.
• The portable devices segment is anticipated to grow at the fastest CAGR during the forecast period.

Based on the End-use Insights, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Ophthalmic Clinics, and Others

• The hospitals segment accounted for the largest market share of more than 35% in 2020. Favorable government policies for the development of eye care facilities in different geographies are one of the major factors responsible for the largest market share of this segment.
• The ophthalmic clinics segment had a considerable market share in 2020. The growing number of ophthalmologists in developing countries is expected to have a significant impact on the market growth with a steep rise in the number of ophthalmic clinics.

Ophthalmic Ultrasound Devices Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

The leading players are focusing on growth strategies, such as innovations in the existing product, frequent product launches, and mergers& acquisitions.

Some prominent players in the global Ophthalmic Ultrasound Devices market include:

• Halma plc
• NIDEK CO. Ltd.
• Quantel Medical
• Optos
• Escalon Medical Corp
• Appasamy Associates
• MicroMedical Devices
• DGH Technology
• Ellex
• Carl Zeiss Meditech

Order a free sample PDF of the Ophthalmic Ultrasound Devices Market Intelligence Study, published by Grand View Research.

Ophthalmic Perimeters Market Organization Segment Trends, PEST Analysis and Forecast

Ophthalmic Perimeters Industry Overview

The global ophthalmic perimeters market size is anticipated to reach USD 371.7 million by 2028, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.3% over the forecast period. The growing frequency of new product launches and an increasing number of strategic alliances between players & end-users are some of the major factors expected to boost growth.

North America is anticipated to dominate the ophthalmic perimeters market during the forecast period owing to rising lifestyle and age-associated ophthalmic conditions such as glaucoma and cataract. An increase in demand for advanced early diagnostic techniques, a high adoption rate for advanced technologies, and favorable reimbursement scenarios are some of the major factors driving the market in the region.

Ophthalmic Perimeters Market Segmentation

Grand View Research has segmented the global ophthalmic perimeters market on the basis of product, application, end-use, and region:

Based on the Product Insights, the market is seagmented into Static, Kinetic, and Combination

• The static perimeter segment dominated the market for ophthalmic perimeters and held the largest revenue share of 37.2% in 2020.
• The combination ophthalmic perimeters segment is expected to witness the fastest CAGR of 4.5% over the forecast period.
• The kinetic perimeter segment is expected to experience significant growth during the forecast period.

Based on the End-use Insights, the market is segmented into Hospital, Ophthalmic Clinic, and Others

• The hospitals segment dominated the market and held the largest revenue share of 42.0% in 2020.
• An increasing number of hospitals in developing countries and increasing competition in healthcare service providers are expected to boost the demand for advanced ophthalmic perimeters during the forecast period.
• The growing prevalence of age and lifestyle associated with eye conditions and the increasing number of ophthalmologists in developing countries are factors expected to fuel the number of ophthalmic clinics. This, in turn, is expected to drive the segment.

Ophthalmic Perimeters Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

A significant number of ophthalmic perimeter manufacturers are in North America. These players are emphasizing on developing user-friendly ophthalmic perimeter devices by developing image processing software. Moreover, key players are conducting workshops and training programs. Such initiatives are expected to boost the overall growth.

Some prominent players in the global Ophthalmic Perimeters market include:

• Haag-Streit AG
• Carl Zeiss AG
• Topcon Corporation
• Nidek Co., Ltd.
• Heidelberg Engineering GmbH
• Optopol Technology Sp. z o.o.
• Takagi Seiko Co., Ltd.
• Kowa Company, Ltd.
• Metrovision
• Konan Medical USA, Inc.
• Centervue S.P.A.

Order a free sample PDF of the Ophthalmic Perimeters Market Intelligence Study, published by Grand View Research.

Neurological Biomarkers Market Driver, Restraint, Challenges and Opportunities Study

Neurological Biomarkers Industry Overview

The global neurological biomarkers market size is expected to reach USD 16.14 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.9% from 2020 to 2028. Increasing funding for the R&D of neurological biomarkers to boost the development of new drugs is expected to accelerate market growth. Moreover, the introduction of novel innovative products for the diagnosis of neurological biomarkers is expected to propel market growth over the forecast period.

The National Institute of Neurological Disorders and Stroke provides funding, such as development grants & cooperative agreements for researchers conducting studies related to biomarker discovery, analytical validation, & clinical validation. Thus, the presence of organizations offering funds at various stages of research is anticipated to drive market growth. For instance, the University of North Texas Health Science Center (HSC) was awarded around USD 45.5 million funds from the National Institutes of Health (NIH) to support research regarding health disparities in Alzheimer’s and brain aging. NIH is offering additional funds for biomarkers research for the ongoing Health and Aging Brain Among Latino Elders (HABLE) study.

Neurological Biomarkers Market Segmentation

Grand View Research has segmented the global neurological biomarkers market on the basis of type, application, end-use, and region:

Based on the Type Insights, the market is segmented into Genomic, Proteomic, Metabolomic, Imaging, and Others

• The proteomic segment accounted for the highest revenue share of over 32% in 2020. Genomic biomarkers accounted for the second-largest market share in 2020.
• The others segment is anticipated to witness significant CAGR over the forecast period due to the increasing adoption of digital biomarkers in clinical trials patient selection for neurological drugs.

Based on the Applications Insights, the market is segmented into Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Autism Spectrum Disorder, and Others

• The Alzheimer’s disease application segment accounted for the largest market share of over 34% in 2020 and is expected to remain dominant during the forecast period.
• The Parkinson’s disease application segment is expected to grow at a CAGR of 13.2% during the forecast period owing to the growing prevalence of the disease and an increasing number of clinical trials for the disease drugs.

Based on the End-use Insights, the market is segmented into Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations & Others

• The hospital & hospital laboratories segment accounted for the largest market share of over 38% in 2020. The segment is expected to remain dominant even during the forecast period due to a rise in hospitalization.
• The research organizations & others segment is expected to grow at the fastest CAGR of more than 13% over the forecast years owing to the increased adoption of biomarkers by pharmaceutical companies and Ambulatory Surgery Centers (ASCs) for drug discovery & development.

Neurological Biomarkers Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Companies are adopting strategies that allow them to use their resources to aid in the development of new products and enhance their supply chain.

Some prominent players in the global Neurological Biomarkers market include:

• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Banyan Biomarkers, Inc.
• Myriad Genetics, Inc.
• DiaGenic ASA
• Quanterix

Order a free sample PDF of the Neurological Biomarkers Market Intelligence Study, published by Grand View Research.

Consumer Genomics Market Size, Challenges Analysis, Porter’s Five Forces Study and Forecast

Consumer Genomics Industry Overview

The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.

Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person’s ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.

Consumer Genomics Market Segmentation

Grand View Research has segmented the global consumer genomics market on the basis of application and region:

Based on the Application Insights, the market is segmented into Genetic Relatedness, Diagnostics, Lifestyle, Wellness, & Nutrition, Ancestry, Reproductive Health, Personalized Medicine & Pharmacogenetic testing, Sports Nutrition & Health, and Others

• The genetic relatedness segment led the market for consumer genomics and accounted for the largest revenue share of 19.9% in 2020.
• The lifestyle, wellness, and nutrition segment is expected to witness the fastest CAGR as consumer genomics tests are claimed to provide personalized nutrition based on an individual’s genotype
• Growing public interest for personalized health has fueled the adoption of nutrigenetic testing services, specifically for optimizing nutrition
• Hence, personalized nutrition is employed to maintain or improve health by using genetic, clinical, and dietary information to provide precise and more efficacious personalized healthy recommendations

Consumer Genomics Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Prominent market players have adopted strategic initiatives to establish their market presence through acquisitions, product launches, and other strategies.

Some prominent players in the global Consumer Genomics market include:

• Ancestry
• Gene By Gene, Ltd. (FamilyTree DNA)
• 23andMe, Inc.
• Color Genomics, Inc
• Myriad Genetics, Inc
• Mapmygenome
• Positive Biosciences, Ltd
• Futura Genetics
• Helix OpCo LLC
• MyHeritage Ltd.
• Pathway Genomics
• Veritas

Order a free sample PDF of the Consumer Genomics Market Intelligence Study, published by Grand View Research.

Advanced Wound Dressing Market Distribution Channel Outlook and Regional Trend Study

Advanced Wound Dressing Industry Overview

The global advanced wound dressing market size is expected to reach USD 9.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. An increasing number of accidents, the impact of COVID-19, and technological advancements are the key driving factors for the market. The increasing incidence of accidents such as road accidents, burns, and trauma events across the globe is anticipated to drive the market. For instance, as per the WHO (2018), around 1,000,000 people are severely or moderately burnt in India per year. In addition, as per NCBI, in 2017, countries such as Bulgaria, Finland, the Netherlands, China, Australia, and the U.K. reported a rise in the incidence of burn injuries.

Furthermore, as per the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died globally, accounting for the deaths of around 3,242 people per day in road accidents every year. Road accidents mostly occur in middle- or low-income countries. The advanced wound dressing is majorly used for the faster healing of all kinds of burns injuries. Moreover, bandages and gauzes are also used for the treatment of minor injuries. Thus, the rising number of accidents is expected to boost the demand for advanced wound dressing, which is expected to lead to considerable market growth over the forecast period.

Advanced Wound Dressing Market Segmentation

Grand View Research has segmented the advanced wound dressing market on the basis of product, application, end-use, and region:

Based on the Products Insights, the market is segmented into Foam, Hydrocolloid, Film, Alginate, Hydrogel, Collagen, and Other Advanced Dressings

• The foam dressings segment dominated the market for advanced wound dressing and accounted for the largest revenue share of 23.6% in 2020.
• The hydrocolloid dressings segment is anticipated to witness the fastest growth rate over the forecast period. Hydrocolloid dressings are made up of gel-forming agents such as Carboxy Methylcellulose (CMC) and gelatin.

Based on the Application Insights, the market is segmented into Chronic Wounds and Acute Wounds

• The acute wounds segment dominated the market for advanced wound dressing and accounted for the largest share of 60.1% in 2020.
• The chronic wounds segment is anticipated to witness a considerable growth rate over the forecast period. The increasing cases of chronic diseases, especially diabetes, and the rising geriatric population in the country are the major driving factors for the segment growth.

Based on the End-use Insights, the market is segmented into Hospitals, Specialty Clinics, Home Healthcare, and Others

• The hospitals' segment dominated the market for advanced wound dressing and accounted for the largest revenue share of 44.9% in 2020. The increasing cases of diabetic foot ulcers and venous leg ulcers are the major driving factors for the growth of the segment.
• Home Healthcare is expected to witness the fastest growth over the forecast period.

Advanced Wound Dressing Regional Outlook

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and launching new products to strengthen their foothold in the market for advanced wound dressing.

Some prominent players in the global Advanced Wound Dressing market include:

• Smith & Nephew PLC
• Mölnlycke Health Care AB
• Convatec Group
• Baxter
• Coloplast Corp
• Medtronic
• 3M
• Derma Sciences Inc.
• Medline Industries, Inc.

Order a free sample PDF of the Advanced Wound Dressing Market Intelligence Study, published by Grand View Research.

U.S. Medical Device Manufacturers Market Profit Margin and Business Environment Study

U.S. Medical Device Manufacturers Industry Overview

The U.S. medical device manufacturers market size is expected to reach USD 262.4 billion by 2028 and is projected to expand at a CAGR of 5.0%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

U.S. Medical Device Manufacturers Market Segmentation

Grand View Research has segmented the U.S. medical device manufacturers market on the basis of type:

Based on the Type Insights, the market is segmented into Diagnostic Imaging, Consumables, Patient Aids, Orthopedics, and Others

• The diagnostic imaging segment captured the largest market share of over 31% in 2020 owing to the high demand for accurate diagnostic methods and devices.
• Chronic diseases accounted for a significant share of the country’s healthcare expenditure, as they require long-term medical care.
• Furthermore, an increase in the number of sports and trauma injuries is boosting demand for orthopedic devices, leading to market growth.

Key Companies Profile & Market Share Insights

New product launches, technological advancements, and capacity expansion are few strategic initiatives undertaken by key players to achieve competitive advantage. New technologies, such as 3D printing, can be used to increase production to meet the sudden upsurge in product demand due to the global coronavirus pandemic. The U.S. government is spending heavily to overcome the shortfalls in medical devices, such as pulse oximeter and N95 respirators.

Some prominent players in the U.S. Medical Device Manufacturers market include:

• 3M Healthcare
• Abbott
• Baxter International, Inc.
• Braun Melsungen AG
• GE Healthcare
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Boston Scientific Corp.

Order a free sample PDF of the U.S. Medical Device Manufacturers Market Intelligence Study, published by Grand View Research.